5381. [Fatal case of cervical cancer treated by anti-neoplastic agents, Bleomycin].5382. [Pre-surgical continuous arterial infusion of antineoplastic agents in osteosarcoma].5383. [Pharmacodynamics of antineoplastic agents in vivo].5384. [Structural anomaly of HeLa cell chromosomes caused by Bleomycin].5386. [Current status of cancer chemotherapy in surgery].5387. [Sensitivity test of Antineoplastic agent sensitivity test in the terminal stage of lung cancer].5388. [Indication for antineoplastic agents (using 3H-thymidine)].5389. [Antineoplastic agent sensitivity test using a diffusion chamber].5390. [Our trial in potentiation of the therapeutic effects of antineoplastic agents on oral cancer].5391. [Evaluation of screening tests using methylcholanthrene-sarcoma].5392. [Indication for antineoplastic agents and administration methods].5393. [Evaluation of antineoplastic agents by INK and MNG methods].5394. [Effect of Bleomycin on the chromosome of HeLa cells].5395. [Simultaneous application of chemotherapy and radiotherapy in lung cancer].5396. [Potentiation of the effects of antineoplastic agents].5397. [The studies on anerobic glycolysis and the inhibition of lactic acid production in Ehrlich's ascites carcinoma by anticancer agents].5398. [Cancer chemotherapy and blood coagulation-fibrinolysis system].5399. [Therapeutic limitation in malignant tumor of the head and neck region, with special reference to the standpoint of chemotherapy].5400. [Combination of various therapeutic agents in the chemotherapy of malignant tumor of the head and neck region]. |